dD4FC development discontinued.
D003570:Cytidine Triphosphate / Q000009:adverse effects / Q000031:analogs & derivatives*; D004345:Drug Industry; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D016047:Zalcitabine / Q000031:analogs & derivatives
D018894:Reverse Transcriptase Inhibitors; D003570:Cytidine Triphosphate; D016047:Zalcitabine; C099405:dexelvucitabine